BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 26527001)

  • 1. APOBEC-Induced Cancer Mutations Are Uniquely Enriched in Early-Replicating, Gene-Dense, and Active Chromatin Regions.
    Kazanov MD; Roberts SA; Polak P; Stamatoyannopoulos J; Klimczak LJ; Gordenin DA; Sunyaev SR
    Cell Rep; 2015 Nov; 13(6):1103-1109. PubMed ID: 26527001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. APOBEC-induced mutations in human cancers are strongly enriched on the lagging DNA strand during replication.
    Seplyarskiy VB; Soldatov RA; Popadin KY; Antonarakis SE; Bazykin GA; Nikolaev SI
    Genome Res; 2016 Feb; 26(2):174-82. PubMed ID: 26755635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers.
    Roberts SA; Lawrence MS; Klimczak LJ; Grimm SA; Fargo D; Stojanov P; Kiezun A; Kryukov GV; Carter SL; Saksena G; Harris S; Shah RR; Resnick MA; Getz G; Gordenin DA
    Nat Genet; 2013 Sep; 45(9):970-6. PubMed ID: 23852170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FHIT loss-induced DNA damage creates optimal APOBEC substrates: Insights into APOBEC-mediated mutagenesis.
    Waters CE; Saldivar JC; Amin ZA; Schrock MS; Huebner K
    Oncotarget; 2015 Feb; 6(5):3409-19. PubMed ID: 25401976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disruption of Transcriptional Coactivator Sub1 Leads to Genome-Wide Re-distribution of Clustered Mutations Induced by APOBEC in Active Yeast Genes.
    Lada AG; Kliver SF; Dhar A; Polev DE; Masharsky AE; Rogozin IB; Pavlov YI
    PLoS Genet; 2015 May; 11(5):e1005217. PubMed ID: 25941824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic inhibitors of APOBEC3B-induced mutagenesis.
    Mertz TM; Rice-Reynolds E; Nguyen L; Wood A; Cordero C; Bray N; Harcy V; Vyas RK; Mitchell D; Lobachev K; Roberts SA
    Genome Res; 2023 Sep; 33(9):1568-1581. PubMed ID: 37532520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrative genomic analysis reveals functional diversification of APOBEC gene family in breast cancer.
    Zhang Y; Delahanty R; Guo X; Zheng W; Long J
    Hum Genomics; 2015 Dec; 9():34. PubMed ID: 26682542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The importance of codon context for understanding the Ig-like somatic hypermutation strand-biased patterns in TP53 mutations in breast cancer.
    Lindley RA
    Cancer Genet; 2013 Jun; 206(6):222-6. PubMed ID: 23880211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breaking bad: The mutagenic effect of DNA repair.
    Chen J; Furano AV
    DNA Repair (Amst); 2015 Aug; 32():43-51. PubMed ID: 26073774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cytidine deaminases AID and APOBEC-1 exhibit distinct functional properties in a novel yeast selectable system.
    Krause K; Marcu KB; Greeve J
    Mol Immunol; 2006 Feb; 43(4):295-307. PubMed ID: 15963568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of germline variants in the APOBEC3 region with cancer risk and enrichment with APOBEC-signature mutations in tumors.
    Middlebrooks CD; Banday AR; Matsuda K; Udquim KI; Onabajo OO; Paquin A; Figueroa JD; Zhu B; Koutros S; Kubo M; Shuin T; Freedman ND; Kogevinas M; Malats N; Chanock SJ; Garcia-Closas M; Silverman DT; Rothman N; Prokunina-Olsson L
    Nat Genet; 2016 Nov; 48(11):1330-1338. PubMed ID: 27643540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APOBEC: From mutator to editor.
    Yang B; Li X; Lei L; Chen J
    J Genet Genomics; 2017 Sep; 44(9):423-437. PubMed ID: 28964683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational processes molding the genomes of 21 breast cancers.
    Nik-Zainal S; Alexandrov LB; Wedge DC; Van Loo P; Greenman CD; Raine K; Jones D; Hinton J; Marshall J; Stebbings LA; Menzies A; Martin S; Leung K; Chen L; Leroy C; Ramakrishna M; Rance R; Lau KW; Mudie LJ; Varela I; McBride DJ; Bignell GR; Cooke SL; Shlien A; Gamble J; Whitmore I; Maddison M; Tarpey PS; Davies HR; Papaemmanuil E; Stephens PJ; McLaren S; Butler AP; Teague JW; Jönsson G; Garber JE; Silver D; Miron P; Fatima A; Boyault S; Langerød A; Tutt A; Martens JW; Aparicio SA; Borg Å; Salomon AV; Thomas G; Børresen-Dale AL; Richardson AL; Neuberger MS; Futreal PA; Campbell PJ; Stratton MR;
    Cell; 2012 May; 149(5):979-93. PubMed ID: 22608084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. APOBEC-mediated DNA alterations: A possible new mechanism of carcinogenesis in EBV-positive gastric cancer.
    Bobrovnitchaia I; Valieris R; Drummond RD; Lima JP; Freitas HC; Bartelli TF; de Amorim MG; Nunes DN; Dias-Neto E; da Silva IT
    Int J Cancer; 2020 Jan; 146(1):181-191. PubMed ID: 31090066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. APOBEC mutagenesis and selection for NFE2L2 contribute to the origin of lung squamous-cell carcinoma.
    Cannataro VL; Kudalkar S; Dasari K; Gaffney SG; Lazowski HM; Jackson LK; Yildiz I; Das RK; Gould Rothberg BE; Anderson KS; Townsend JP
    Lung Cancer; 2022 Sep; 171():34-41. PubMed ID: 35872531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of gene expression and mutation data points on contribution of transcription to the mutagenesis by APOBEC enzymes.
    Chervova A; Fatykhov B; Koblov A; Shvarov E; Preobrazhenskaya J; Vinogradov D; Ponomarev GV; Gelfand MS; Kazanov MD
    NAR Cancer; 2021 Sep; 3(3):zcab025. PubMed ID: 34316712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of Genomic Alteration from Cytidine Deamination.
    Liu X; Meng FL
    Adv Exp Med Biol; 2018; 1044():49-64. PubMed ID: 29956291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA replication stress: a source of APOBEC3B expression in breast cancer.
    Cescon DW; Haibe-Kains B
    Genome Biol; 2016 Sep; 17(1):202. PubMed ID: 27716362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide mutation avalanches induced in diploid yeast cells by a base analog or an APOBEC deaminase.
    Lada AG; Stepchenkova EI; Waisertreiger IS; Noskov VN; Dhar A; Eudy JD; Boissy RJ; Hirano M; Rogozin IB; Pavlov YI
    PLoS Genet; 2013; 9(9):e1003736. PubMed ID: 24039593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An APOBEC3A hypermutation signature is distinguishable from the signature of background mutagenesis by APOBEC3B in human cancers.
    Chan K; Roberts SA; Klimczak LJ; Sterling JF; Saini N; Malc EP; Kim J; Kwiatkowski DJ; Fargo DC; Mieczkowski PA; Getz G; Gordenin DA
    Nat Genet; 2015 Sep; 47(9):1067-72. PubMed ID: 26258849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.